SEATTLE, WA ( January 8, 2021) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced financial results for the fiscal third quarter ended November 30, 2020.
SEATTLE, WA (October 14, 2020) - Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced financial results for the fiscal second quarter ended August 31, 2020.
SEATTLE, WA (August 13, 2020) – Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced financial results for the fiscal first quarter ended May 31, 2020.
Seattle, WA (July 1, 2020) - Accolade, Inc. ("Accolade"), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced the pricing of its initial public offering of 10,022,726 shares of its common stock at a price to the public of $22.00 per share. The shares are expected to begin trading on The Nasdaq Global Select Market under the ticker symbol "ACCD" on July 2, 2020, and the offering is expected to close on July 7, 2020, subject to customary closing conditions. In addition, Accolade has granted the underwriters a 30-day option to purchase up to 1,503,408 additional shares of common stock at the initial public offering price less the underwriting discount and commissions.
Seattle, WA (February 28, 2020) – Accolade, Inc. (“Accolade”), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Accolade intends to list its common stock on the Nasdaq Global Select Market under the ticker symbol ACCD.
Former Health Technology Advisor to the World Bank and Technology Innovator in AI and Commercial Healthcare Solutions to Lead Accolade's Clinical Strategy and Vision
Working together, the companies will use people plus technology to drive pharmacy benefit engagement and savings for employers and members
Ten-step Partner Validation Process Designed to Achieve Highest Quality, Value and Results for Employers, with Personalized Engagement Strategies around Diabetes, Second Opinion, Telemedicine, Women's Health and More
Strategic Investment from Humana Designed to Strengthen and Expand the Integrated Offering from Accolade and Humana
Former Microsoft Executive Peter Klein to Join Accolade Board
New Healthcare Solution Combines Provider Quality Insights Gained through the Acquisition of MD Insider, Cost Transparency and Personalized Support from Accolade Nurses
Former chairman and CEO of drugstore.com joins prestigious group of healthcare, technology and business executives working to change the healthcare experience in the U.S.
Seattle (June 17, 2019) - Accolade and EY today announced that Rajeev Singh, CEO of Accolade, a personalized advocacy solution for employers and their members, received the Entrepreneur Of The Year® 2019 Award in the Innovator category, Pacific Northwest region. As the world's most prestigious business awards program for entrepreneurs, Entrepreneur Of The Year recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities, while also transforming our world. Singh was selected by an independent panel of judges, and the award was presented at a black-tie gala event in Seattleon June 14.
(Seattle & Louisville, KY) - Mar 15, 2019--Accolade and Humana Inc. (NYSE: HUM) announced today that the two companies will integrate their capabilities to create a differentiated healthcare and benefits experience for consumers. The companies will bring employers and their health plan members the benefit of Humana’s provider networks and innovative medical, dental, pharmacy, Employee Assistance Program (EAP), Work-life Services, and Go365 wellness reward program capabilities together with Accolade’s robust member engagement services and integrated health and benefits partner programs.
Global Technology Company Apptio Modernizes and Simplifies their Employee Healthcare and Benefits Experience by Bringing Accolade Connect to its Employees and their Family Members
SEATTLE, Nov. 20, 2018 /PRNewswire/ -- Innovative health and benefits strategies can fundamentally improve the healthcare experience, outcomes and cost structure for more than 180 million people receiving employer-sponsored health insurance in the U.S., according to Personalized Advocacy provider Accolade. The company's CEO Rajeev Singhwill share these strategies and independently validated outcomes research at the upcoming Piper Jaffray Annual Healthcare Conference in New York City November 28th.